An international team of researchers has demonstrated that the tetravalent dengue vaccine known as Qdenga provided significant protection against the disease under real-world conditions, during the large 2024 epidemic in São Paulo, Brazil.
Dengue vaccine shows effectiveness under real-world conditions during Brazil’s 2024 outbreak
